Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 12 May 2021
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 12 May 2021. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
In response to a DSE query dated May 09, 2021 regarding clarification on recent news published in the newspaper on launching factory in Kenya, the Company has informed that "It is a 100% subsidiary of Square Pharmaceuticals Limited, Bangladesh and the construction of the pharmaceuticals manufacturing facility in Nairobi, Kenya is at finishing stage. It shall go for commercial production subject to completion of Kenyan regulatory compliance process by August 2021."
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b0000400538e5
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.